Molecule Details
InChIKeyMTCUAOILFDZKCO-UHFFFAOYSA-N
Compound NameDecamethonium
Canonical SMILESC[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Cross-Family
Avg pChEMBL6.47
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB01245
Drug NameDecamethonium
CAS Number156-74-1
Groups approved
ATC Codes nan
DescriptionDecamethonium is used in anesthesia to cause paralysis. It is a short acting depolarizing muscle relaxant. It is similar to acetylcholine and acts as a partial agonist of the nicotinic acetylcholine receptor.

Categories: Amines Bis-Trimethylammonium Compounds Central Nervous System Depressants Cholinesterase Inhibitors Neuromuscular Agents Neuromuscular Blocking Agents Neuromuscular Depolarizing Agents Neurotoxic agents Onium Compounds Peripheral Nervous System Agents Quaternary Ammonium Compounds
Cross-references: BindingDB: 50060582 ChEBI: 41934 CHEMBL1190 ChemSpider: 2862 C11733 PDB: DME PharmGKB: PA164747980 PubChem:2968 PubChem:46507737 Therapeutic Targets Database: DAP000378 Wikipedia: Decamethonium ZINC: ZINC000001532339
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
P08172 CHRM2 Homo sapiens Human PF00001 7.6 Ki BindingDB
P43681 CHRNA4 Homo sapiens Human PF02931 PF02932 6.2 Ki BindingDB
Q9Y5N1 HRH3 Homo sapiens Human PF00001 6.1 IC50 ChEMBL;BindingDB
P22303 ACHE Homo sapiens Human PF08674 PF00135 6.0 IC50 ChEMBL;BindingDB
DrugBank Target Actions (6)
Target Gene Target Name Action Type
P06276 BCHE Cholinesterase inhibitor enzymes
P17787 CHRNB2 Neuronal acetylcholine receptor subunit beta-2 binder targets
P43681 CHRNA4 Neuronal acetylcholine receptor subunit alpha-4 binder targets
P22303 ACHE Acetylcholinesterase inhibitor targets
P02708 CHRNA1 Acetylcholine receptor subunit alpha modulator targets
Q15822 CHRNA2 Neuronal acetylcholine receptor subunit alpha-2 partial agonist targets